company background image
IIQ logo

INOVIQ ASX:IIQ Stock Report

Last Price

AU$0.64

Market Cap

AU$57.1m

7D

13.3%

1Y

20.8%

Updated

18 Jun, 2024

Data

Company Financials +

IIQ Stock Overview

Engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

IIQ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

INOVIQ Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for INOVIQ
Historical stock prices
Current Share PriceAU$0.64
52 Week HighAU$0.99
52 Week LowAU$0.47
Beta2.26
1 Month Change25.49%
3 Month Change9.40%
1 Year Change20.75%
3 Year Change-65.22%
5 Year Change-26.44%
Change since IPO-11.11%

Recent News & Updates

We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

Apr 22
We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

Mar 01
A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Nov 22
We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Recent updates

We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

Apr 22
We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

Mar 01
A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Nov 22
We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Jun 21
Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Feb 16
Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

INOVIQ (ASX:IIQ) Is In A Good Position To Deliver On Growth Plans

Sep 28
INOVIQ (ASX:IIQ) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash Wisely

Jun 08
We're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash Wisely

We're Keeping An Eye On INOVIQ's (ASX:IIQ) Cash Burn Rate

Jan 28
We're Keeping An Eye On INOVIQ's (ASX:IIQ) Cash Burn Rate

Are Insiders Selling BARD1 Life Sciences Limited (ASX:BD1) Stock?

Mar 02
Are Insiders Selling BARD1 Life Sciences Limited (ASX:BD1) Stock?

Don't Ignore The Fact That This Insider Just Sold Some Shares In BARD1 Life Sciences Limited (ASX:BD1)

Mar 02
Don't Ignore The Fact That This Insider Just Sold Some Shares In BARD1 Life Sciences Limited (ASX:BD1)

BARD1 Life Sciences (ASX:BD1) Is In A Good Position To Deliver On Growth Plans

Dec 28
BARD1 Life Sciences (ASX:BD1) Is In A Good Position To Deliver On Growth Plans

Shareholder Returns

IIQAU HealthcareAU Market
7D13.3%1.5%-2.0%
1Y20.8%-21.5%6.1%

Return vs Industry: IIQ exceeded the Australian Healthcare industry which returned -21.5% over the past year.

Return vs Market: IIQ exceeded the Australian Market which returned 6.1% over the past year.

Price Volatility

Is IIQ's price volatile compared to industry and market?
IIQ volatility
IIQ Average Weekly Movement16.3%
Healthcare Industry Average Movement5.7%
Market Average Movement8.6%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: IIQ's share price has been volatile over the past 3 months.

Volatility Over Time: IIQ's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1983n/aLeearne Hinchwww.inoviq.com

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers.

INOVIQ Ltd Fundamentals Summary

How do INOVIQ's earnings and revenue compare to its market cap?
IIQ fundamental statistics
Market capAU$57.05m
Earnings (TTM)-AU$6.51m
Revenue (TTM)AU$1.58m

37.2x

P/S Ratio

-9.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IIQ income statement (TTM)
RevenueAU$1.58m
Cost of RevenueAU$3.26m
Gross Profit-AU$1.68m
Other ExpensesAU$4.83m
Earnings-AU$6.51m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.071
Gross Margin-105.79%
Net Profit Margin-410.78%
Debt/Equity Ratio0%

How did IIQ perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.